Merck’s patent for once weekly Fosomax successfully opposed in Israel by Unipharm and Teva, on grounds of obviousness.
patentable subject matter
The UK Intellectual Property Office (IPO) has announced that the pilot work-sharing programme, the Patent Prosecution Highway (PPH), between the IPO and the Japanese Patent Office has now been made permanent. Under (or should that be on???) the Highway, once… Read More ›
Israel Commissioner Limits Possibility of Filing Divisional Applications to Lifetime of the Parent Application
Israel Commissioner of Patents clarifies Section of Patent Law of dubious ambiguity, but is he exceeding his authority?
An appeals board of the U.S. Patent and Trademark Office (USPTO) has partially rejected a patent on Pfizer Inc’s impotence drug Viagra because it works in a way similar to the Chinese herb Yin Yang Huo, otherwise known as Horny… Read More ›
A rare ruling on a patent restricted by the Israeli Government, as being of secu restricted inventions.
Greenpeace considers that the German patent office was wrong to issue a patent number DE 19756864 to Oliver Brüstle, and the Germans have turned to the European Court of Justice for a ruling concerning Art. 6 of Directive 98/44/EC which… Read More ›
On the 15 October 2009, a round table was held between representatives of the patent practitioner professions and relevant staff of the Israel Patent Office. Patent Attorney Ehud Hausman took the initiative and worked for 2 years to organize the round… Read More ›
Israel Patent Office hosts seminar on chemistry and pharmaceutical patents
Preempting the US Supreme Court’s review of patentable inventions (re Bilski), the USPTO deputy commissioner has issued some nifty guidelines and rather inane flow-charts demonstrating to those requiring intellectual examination what a machine is or what a transformation is. See Dennis Crouch’s Patently-O: http://www.patentlyo.com/patent/2009/08/interim-guidelines-on-statutory-subject-matter.html… Read More ›